CDH2 and liver cancer: Own preliminary results in this respect demonstrated the absence of N-cadherin in most gastrointestinal, tuboovarial, mammary, and lung adenocarcinomas, as well as urothelial carcinomas, so N-cadherin may even help in the differential diagnosis of primary liver cancer from liver metastases of adenocarcinomas of unknown primary tumors.